Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Late-breaking abstract: Pneumococcal serotypes causing community-acquired pneumonia (CAP) among hospitalized adults in Spain using a new urinary antigen detection (UAD) test. The CAPA study

Rosario Menéndez, Antoni Torres, Pedro Pablo España, Emilio Pérez-Trallero, José Luis López Hontangas, Francesc Marco, Ana Patricia Martínez de la Fuente, José María Marimón, Alexandra Gimeno, Catia Cilloniz, Ane Uranga, María Ercibengoa, César Balseiro, Cristina Méndez
European Respiratory Journal 2014 44: P1810; DOI:
Rosario Menéndez
1Pneumology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoni Torres
2Pneumology, Hospital Clinic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Pablo España
3Pneumology, Hospital Usansolo-Galdakao, Galdácano, Vizcaya, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emilio Pérez-Trallero
4Microbiology, Hospital Universitario Donostia, San Sebastián, Guipuzcoa, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Luis López Hontangas
1Pneumology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesc Marco
2Pneumology, Hospital Clinic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Patricia Martínez de la Fuente
3Pneumology, Hospital Usansolo-Galdakao, Galdácano, Vizcaya, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José María Marimón
4Microbiology, Hospital Universitario Donostia, San Sebastián, Guipuzcoa, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Gimeno
1Pneumology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catia Cilloniz
2Pneumology, Hospital Clinic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ane Uranga
3Pneumology, Hospital Usansolo-Galdakao, Galdácano, Vizcaya, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Ercibengoa
4Microbiology, Hospital Universitario Donostia, San Sebastián, Guipuzcoa, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
César Balseiro
5Microbiology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina Méndez
5Microbiology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Background and objective: Widespread use of PCV7/PCV13 in children has resulted in a significant reduction of pneumococcal diseases in adults. Pneumococcal pneumonias due to PCV13 vaccine serotypes particularly in CAP without bacteremia are not known. In Spain, where PCV13 is mainly available in private market for healthy children (estimated uptake ≈70%), we assessed the burden of disease caused by PCV13 serotypes in immunocompetent subjects >18 years hospitalized with CAP in 3 Spanish hospitals (November 2011-May 2013).

Methods: In subjects hospitalized with CAP, microbiological confirmation was sought by the novel UAD (Pfizer's PCV13 serotype specific urinary antigen detection test), BinaxNow & conventional cultures. Serotyping of pneumococcal isolates was accomplished in a central laboratory using Quellung reaction.

Results: S. pneumoniae infection was microbiologically confirmed in 232 cases (30.7%) of 756 enrolled patients by any diagnostic test. Positivity rates for the different tests were: UAD: 63%; BinaxNow: 57.3%; blood cultures: 16.8%; pleural fluid culture: 2.5%; sputum: 9.4% and others: 0.8%. Table shows PCV13 vaccine type distribution in invasive1 and non-invasive2 pneumococcal CAP.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Conclusion: Almost 20% of hospitalized CAP in immunocompetent adults in Spain were caused by one of the serotypes included in PCV13.

  • Pneumonia
  • Epidemiology
  • Vaccination
  • © 2014 ERS
Previous
Back to top
Vol 44 Issue Suppl 58 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Late-breaking abstract: Pneumococcal serotypes causing community-acquired pneumonia (CAP) among hospitalized adults in Spain using a new urinary antigen detection (UAD) test. The CAPA study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Late-breaking abstract: Pneumococcal serotypes causing community-acquired pneumonia (CAP) among hospitalized adults in Spain using a new urinary antigen detection (UAD) test. The CAPA study
Rosario Menéndez, Antoni Torres, Pedro Pablo España, Emilio Pérez-Trallero, José Luis López Hontangas, Francesc Marco, Ana Patricia Martínez de la Fuente, José María Marimón, Alexandra Gimeno, Catia Cilloniz, Ane Uranga, María Ercibengoa, César Balseiro, Cristina Méndez
European Respiratory Journal Sep 2014, 44 (Suppl 58) P1810;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Late-breaking abstract: Pneumococcal serotypes causing community-acquired pneumonia (CAP) among hospitalized adults in Spain using a new urinary antigen detection (UAD) test. The CAPA study
Rosario Menéndez, Antoni Torres, Pedro Pablo España, Emilio Pérez-Trallero, José Luis López Hontangas, Francesc Marco, Ana Patricia Martínez de la Fuente, José María Marimón, Alexandra Gimeno, Catia Cilloniz, Ane Uranga, María Ercibengoa, César Balseiro, Cristina Méndez
European Respiratory Journal Sep 2014, 44 (Suppl 58) P1810;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Is empirical antibiotic treatment correlated to outcome in microbiology-negative pleural infection?
  • Effect of N-acetylcysteine on the activity of antibiotics against relevant respiratory pathogens
  • Longitudinal performance of the bronchiectasis severity index (BSI) in patients on regular intravenous (IV) antibiotic therapy for bronchiectasis
Show more 10.1 Respiratory Infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society